2010 Pipeline Report
HIV, Tuberculosis, and Viral Hepatitis: Drugs, diagnostics, Vaccines, Immune-based therapies, and Preventive Technologies in Development. By Polly Clayden, Lei Chou, Simon Collins, Mark Harrington, Richard Jefferys, Eleonora Jimenez, Scott Morgan, Tracy Swan, Javid Syed and Claire Wingfield.
Monitoring TB/HIV Indicators for UNGASS: Kenya, Uganda and Zambia
January 2010 - Despite being curable, Tuberculosis (TB) continues to be the leading cause of death among people with HIV in 2008, accounting for 25% of all HIV-related deaths. The World Health Organization (WHO) has developed a 12-point policy package…
2009 Pipeline Report
HIV, Tuberculosis, and Viral Hepatitis: Drugs, diagnostics, Vaccines, and Microbicides in Development July 2009 By Lei Chou, Mark Harrington, Bob Huff, Richard Jefferys, Javid Syed, and Claire Wingfield TAG’s annual Pipeline Reportsurveys the developments in medicines and diagnostics most likely…
Guide to Hepatitis B for people living with HIV
June 2009 By Lei Chou INTRODUCTION Welcome to this treatment guide for HIV-positive people who also have hepatitis B (HBV). This guide provides information on the prevention, care, and treatment of HBV, and the impact of HBV on HIV disease…
Flat-Lined: How Flat NIH Funding Undermines Research on HIV, Tuberculosis, and Viral Hepatitis
May 2009 by Lydia H. Guterman Edited by Mark Harrington Executive Summary The goal of this funding analysis is to provide a comprehensive picture of the current state of U.S. National Institutes of Health (NIH) research investment in HIV/AIDS and…
2008 Pipeline Report
HIV, Tuberculosis, Hepatitis B, and Hepatitis C: Drugs, Diagnostics, Vaccines, and Microbicides in Development by Lei Chou, Mark Harrington, Bob Huff, Richard Jefferys, Tracy Swan, Javid Syed, and Claire Wingfield This Report was released at the XVII International AIDS Conference…
Hepatitis C: New Treatments in the Pipeline
By Tracy Swan April 2008 From the Introduction Hepatitis C virus (HCV) is a serious global health problem. According to the World Health Organization (WHO), which describes HCV as a “viral time bomb,” 130 million people have chronic hepatitis C,…